Einsele, Hermann ; Engelhardt, Monika ; Tapprich, Christoph ; Müller, Jürgen ; Liebisch, Peter ; Langer, Christian ; Kropff, Martin ; Mügge, Lars O. ; Jung, Wolfram ; Wolf, Hans-Heinrich ; Metzner, Bernd ; Hart, Christina ; Gramatzki, Martin ; Hertenstein, Bernd ; Pfreundschuh, Michael ; Rösler, Wolf ; Fischer, Thomas ; Maschmeyer, Georg ; Kanz, Lothar ; Hess, Georg ; Jäger, Elke ; Bentz, Martin ; Dürk, Heinz A. ; Salwender, Hans 
; Hebart, Holger ; Straka, Christian ; Knop, Stefan
; Hebart, Holger ; Straka, Christian ; Knop, Stefan 
Zusammenfassung
We assessed the safety and efficacy of bortezomib, cyclophosphamide and dexamethasone (VCD) induction therapy in previously untreated multiple myeloma patients. A total of 414 patients received three 21-day cycles of VCD prior to autologous stem-cell transplantation (ASCT). Most common grade >= 3 adverse events were leucopenia (31.4%) and thrombocytopenia (6.8%). The overall response rate (ORR) ...
Nur für Besitzer und Autoren: Kontrollseite des Eintrags
Altmetric